GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient Groups

Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy

NCT01961388 ·Status: WITHDRAWN

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

NCT01316861 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study for Acarbose/Metformin FDC

NCT04065581 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes

NCT00568074 ·Status: COMPLETED ·Phase: PHASE4

Safety and Tolerability, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Three Doses of BI 187004 Over 28 Days in Patients With Type 2 Diabetes Mellitus With and Without Metformin

NCT02150824 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study for Acarbose / Metformin FDC

NCT01728740 ·Status: COMPLETED ·Phase: PHASE1

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

NCT00035542 ·Status: COMPLETED ·Phase: PHASE3

Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Single Doses of CM3.1-AC100 in Patients With Type 2 Diabetes

NCT01196728 ·Status: COMPLETED ·Phase: PHASE1

A 3-fold Crossover Bioequivalence Study Between Glucobay ODT (Orally Disintegrating Tablet) 100 mg and Glucobay Standard Tablet 100 mg

NCT01554631 ·Status: COMPLETED ·Phase: PHASE1

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

NCT01388153 ·Status: COMPLETED ·Phase: PHASE1

A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes

NCT00035568 ·Status: COMPLETED ·Phase: PHASE4

A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes

NCT02053272 ·Status: COMPLETED ·Phase: PHASE2

A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate

NCT00740051 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes

NCT00622284 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

NCT01159600 ·Status: COMPLETED ·Phase: PHASE3

Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed

NCT00835991 ·Status: COMPLETED ·Phase: PHASE1

GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients

NCT00291356 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes

NCT00601250 ·Status: COMPLETED ·Phase: PHASE3

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

NCT01725126 ·Status: COMPLETED ·Phase: PHASE2

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

NCT00423501 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

NCT02583919 ·Status: COMPLETED ·Phase: PHASE2

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

NCT00388986 ·Status: COMPLETED ·Phase: PHASE1

The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions

NCT06244407 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

NCT00328172 ·Status: COMPLETED ·Phase: PHASE2

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

NCT00460941 ·Status: COMPLETED ·Phase: PHASE2